Medical Information
United States
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

Información selecta para pacientes y cuidadores que se encuentra disponible en Español.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

ZARONTIN® Oral Solution Principal Display Panel (ethosuximide)

PRINCIPAL DISPLAY PANEL - 474 mL Bottle Label - 2418-23

ALWAYS DISPENSE WITH
ACCOMPANYING MEDICATION GUIDE

NDC 0071-2418-23

Pfizer

Zarontin®
(Ethosuximide)
ORAL SOLUTION

250 mg per 5 mL

1 Pint (474 mL)
Rx only

PRINCIPAL DISPLAY PANEL - 474 mL Bottle Label - 2418-23

PRINCIPAL DISPLAY PANEL - 474 mL Bottle Carton - 2418-23

ALWAYS DISPENSE WITH
ACCOMPANYING MEDICATION GUIDE

NDC 0071-2418-23

Pfizer

Zarontin®
(Ethosuximide)
ORAL SOLUTION

250 mg per 5 mL

1 Pint (474 mL)
Rx only

PRINCIPAL DISPLAY PANEL - 474 mL Bottle Carton - 2418-23

PRINCIPAL DISPLAY PANEL - 474 mL Bottle Label - 2418-35

ALWAYS DISPENSE WITH
ACCOMPANYING MEDICATION GUIDE

Pfizer
NDC 0071-2418-35

Zarontin®
(Ethosuximide)
ORAL SOLUTION

250 mg per 5 mL

1 Pint (474 mL)
Rx only

PRINCIPAL DISPLAY PANEL - 474 mL Bottle Label - 2418-35

PRINCIPAL DISPLAY PANEL - 474 mL Bottle Carton - 2418-35

ALWAYS DISPENSE WITH
ACCOMPANYING MEDICATION GUIDE

Pfizer
NDC 0071-2418-35

Zarontin®
(Ethosuximide)
ORAL SOLUTION

250 mg per 5 mL

1 Pint (474 mL)
Rx only

PRINCIPAL DISPLAY PANEL - 474 mL Bottle Carton - 2418-35
Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.
Report Adverse Event